Mitsubishi Ufj Trust & Banking Corp Biomarin Pharmaceutical Inc Transaction History

Mitsubishi Ufj Trust & Banking Corp

  • $43.4 Billion
  • Q3 2024

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 209,908 shares of BMRN stock, worth $13.9 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
209,908
Previous 184,009 14.07%
Holding current value
$13.9 Million
Previous $15.1 Million 2.61%
% of portfolio
0.03%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$69.02 - $93.84 $1.79 Million - $2.43 Million
25,899 Added 14.07%
209,908 $14.8 Million
Q2 2024

Aug 08, 2024
BUY
$74.43 - $92.22 $358,157 - $443,762
4,812 Added 2.69%
184,009 $15.1 Million
Q1 2024

May 10, 2024
SELL
$83.81 - $99.0 $668,971 - $790,218
-7,982 Reduced 4.26%
179,197 $15.7 Million
Q4 2023

Feb 09, 2024
BUY
$76.22 - $98.51 $609,683 - $787,981
7,999 Added 4.46%
187,179 $18 Million
Q3 2023

Nov 09, 2023
SELL
$85.07 - $94.48 $306,847 - $340,789
-3,607 Reduced 1.97%
179,180 $15.9 Million
Q2 2023

Aug 08, 2023
BUY
$86.68 - $100.3 $161,744 - $187,159
1,866 Added 1.03%
182,787 $15.8 Million
Q1 2023

May 10, 2023
BUY
$87.74 - $117.27 $222,947 - $297,983
2,541 Added 1.42%
180,921 $17.6 Million
Q4 2022

Feb 10, 2023
BUY
$80.93 - $108.63 $32,614 - $43,777
403 Added 0.23%
178,380 $18.5 Million
Q3 2022

Nov 10, 2022
SELL
$82.16 - $96.94 $3.39 Million - $4 Million
-41,295 Reduced 18.83%
177,977 $15.1 Million
Q2 2022

Aug 09, 2022
BUY
$71.48 - $86.85 $2.12 Million - $2.57 Million
29,638 Added 15.63%
219,272 $18.2 Million
Q1 2022

May 12, 2022
SELL
$74.28 - $92.69 $1.09 Million - $1.36 Million
-14,698 Reduced 7.19%
189,634 $14.6 Million
Q4 2021

Feb 09, 2022
BUY
$71.72 - $91.47 $6.59 Million - $8.4 Million
91,876 Added 81.7%
204,332 $18.1 Million
Q3 2021

Nov 12, 2021
BUY
$74.77 - $85.47 $196,794 - $224,957
2,632 Added 2.4%
112,456 $8.69 Million
Q2 2021

Aug 12, 2021
SELL
$75.51 - $84.79 $884,977 - $993,738
-11,720 Reduced 9.64%
109,824 $9.16 Million
Q1 2021

May 12, 2021
SELL
$74.73 - $90.69 $1.64 Million - $1.99 Million
-21,979 Reduced 15.31%
121,544 $9.2 Million
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $493,384 - $612,909
6,795 Added 4.97%
143,523 $12.6 Million
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $254,204 - $463,453
-3,537 Reduced 2.52%
136,728 $10.4 Million
Q2 2020

Sep 11, 2020
SELL
$79.55 - $124.22 $1.1 Million - $1.72 Million
-13,853 Reduced 8.99%
140,265 $17.3 Million
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $893,426 - $1.4 Million
11,231 Added 7.86%
154,118 $17.3 Million
Q1 2020

May 13, 2020
BUY
$71.37 - $96.85 $598,794 - $812,571
8,390 Added 6.24%
142,887 $12.1 Million
Q4 2019

Feb 14, 2020
SELL
$64.27 - $86.37 $78,666 - $105,716
-1,224 Reduced 0.9%
134,497 $11.4 Million
Q3 2019

Nov 12, 2019
SELL
$67.4 - $85.11 $229,362 - $289,629
-3,403 Reduced 2.45%
135,721 $9.27 Million
Q2 2019

Aug 07, 2019
BUY
$80.35 - $93.9 $430,354 - $502,928
5,356 Added 4.0%
139,124 $11.7 Million
Q1 2019

May 13, 2019
BUY
$84.2 - $98.62 $27,196 - $31,854
323 Added 0.24%
133,768 $11.7 Million
Q4 2018

Feb 12, 2019
BUY
$80.14 - $106.07 $163,966 - $217,019
2,046 Added 1.56%
133,445 $11.4 Million
Q3 2018

Nov 13, 2018
SELL
$93.92 - $105.72 $21 Million - $23.7 Million
-223,991 Reduced 63.03%
131,399 $12.7 Million
Q2 2018

Aug 10, 2018
BUY
$76.01 - $99.03 $186,072 - $242,425
2,448 Added 0.69%
355,390 $33.5 Million
Q1 2018

May 11, 2018
BUY
$77.67 - $92.63 $72,543 - $86,516
934 Added 0.27%
352,942 $28.6 Million
Q4 2017

Feb 09, 2018
BUY
$80.76 - $95.13 $5,330 - $6,278
66 Added 0.02%
352,008 $31.4 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $28.4 Million - $33.4 Million
351,942
351,942 $32.8 Million

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email